Cuu Long Pharmaceutical Joint Stock Company (HOSE: DCL)
Health Care · Pharmaceuticals · VN
₫38,500.00
+0.79% today · +84.7% 1Y
Cuu Long Pharmaceutical Joint Stock Company (HOSE: DCL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $107.67M.
Over the last twelve months the share price has gained 84.7%, trading between 20.85K and 62.80K.
Tweenvest scores Cuu Long Pharmaceutical Joint Stock Company across four factors: quality 55/100, value 40/100, growth 32/100. Its strongest factor is quality.
DCL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $107.67M
- Revenue (TTM)
- $48.17M
- P/E
- —
- EPS
- -31.09
- Dividend yield
- —
- Beta (5Y)
- 0.11
- 52-week high
- ₫62,800.00
- 52-week low
- ₫20,850.00
- Avg volume (3M)
- —
- Shares outstanding
- 73.04M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.50 | -0.01% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.20 | +0.02% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.